Results & Dividends

Neimeth Post N288.5 Million Loss in 2014

Posted by InvestAdvocate on

More in Results & Dividends:

By Yakubu LAAH InvestAdvocate

Lagos (INVESTADVOCATE)-Nigerian drugmaker, Neimeth International Pharmaceutical Plc on Tuesday posted a loss of N288.5 million in the audited period ended September 30, 2014, the drug maker said in a filing with the Nigerian Stock Exchange (NSE).

According to the company, profit after tax (PAT) went down from a profit of N130.57 million in 2013 end to a loss of N228.5 million; indicating a decline of 275 percent.

Similarly, profit before tax (PBT) declined 208.8 percent to a loss of N198.27 million from a profit of N182.13 million recorded in corresponding period of 2013.

Revenue of Neimeth dipped 19.2 percent to N1.628 billion recorded in 2014 end from N2.016 billion posted in the same period of 2013.

Comments are closed.